Dupilumab improves histologic and endoscopic aspects of eosinophilic esophagitis (EoE), as well as rate of weight gain, in children aged 1 to < 12 years: 52-week results from the Phase 3 EoE KIDS trial

被引：0

作者：

von Arnim, Ulrike ^{[1
]}

Chehade, Mirna ^{[2
]}

Dellon, Evan S. ^{[3
]}

Spergel, Jonathan M. ^{[4
]}

Rothenberg, Marc E. ^{[5
]}

Pesek, Robert D. ^{[6
,7
]}

Collins, Margaret H.

Hirano, Ikuo ^{[8
]}

Liu, Ruiqi ^{[9
]}

Laws, Elizabeth ^{[10
]}

Mortensen, Eric ^{[9
]}

Abdulai, Raolat M. ^{[11
]}

Maloney, Jennifer ^{[9
]}

McCann, Eilish ^{[9
]}

Kosloski, Matthew P. ^{[9
]}

Hamilton, Jennifer D. ^{[9
]}

Samuely, Carin ^{[9
]}

Glotfelty, Lila

Shabbir, Arsalan ^{[9
]}

机构：

[1] Univ Hosp Magdeburg, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany

[2] Icahn Sch Med Mt Sinai, Mt Sinai Ctr Eosinophil Disorders, New York, NY USA

[3] Univ N Carolina, Div Gastroenterol & Hepatol, Dept Med, Sch Med, Chapel Hill, NC USA

[4] Childrens Hosp Philadelphia, Ctr Pediat Eosinophil Disorders, Philadelphia, PA USA

[5] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Coll Med, Cincinnati, OH USA

[6] Univ Arkansas Med Sci, Little Rock, AR USA

[7] Arkansas Childrens Hosp, Div Allergy Immunol, Dept Pediat, Little Rock, AR USA

[8] Northwestern Univ, Dept Med Gastroenterol & Hepatol, Feinberg Sch Med, Chicago, IL USA

[9] Regeneron Pharmaceut Inc, Regeneron, Tarrytown, NY USA

[10] Sanofi, Bridgewater, NJ USA

[11] Sanofi, Cambridge, MA USA

来源：

INNERE MEDIZIN | 2024年 / 65卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P05-02

引用

页码：S38 / S38

页数：1

共 23 条

[1] DUPILUMAB IMPROVES HISTOLOGIC AND ENDOSCOPIC OUTCOMES IN CHILDREN AGED 1 TO <12 YEARS WITH EOSINOPHILIC ESOPHAGITIS (EOE): 52-WEEK RESULTS FROM THE PHASE 3 EOE KIDS TRIAL
Chehade, Mirna
Dellon, Evan S.
Spergel, Jonathan
Rothenberg, Marc E.
Pesek, Robert
Collins, Margaret H.
Hirano, Ikuo
Liu, Ruiqi
Laws, Elizabeth
Mortensen, Eric R.
Abdulai, Raolat M.
Maloney, Jennifer
McCann, Eilish
Kosloski, Matthew
Hamilton, Jennifer D.
Samuely, Carin
Glotfelty, Lila
Shabbir, Arsalan
GASTROENTEROLOGY, 2024, 166 (05) : S402 - S402
[2] Dupilumab Improves Histologic And Endoscopic Outcomes In Children Aged 1 To <<12 Years With Eosinophilic Esophagitis (EoE): 52-Week Results From The Phase 3 EoE KIDS Trial
Chehade, Mirna
Dellon, Evan
Spergel, Jonathan
Rothenberg, Marc
Pesek, Robert
Collins, Margaret
Hirano, Ikuo
Liu, Ruiqi
Laws, Elizabeth
Mortensen, Eric
Martincova, Renata
Maloney, Jennifer
McCann, Eilish
Kosloski, Matthew
Hamilton, Jennifer
Samuely, Carin
Glotfelty, Lila
Shabbir, Arsalan
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB266 - AB266
[3] DUPILUMAB IMPROVES ESOPHAGEAL FEATURES OF EOSINOPHILIC ESOPHAGITIS (EOE) AS MEASURED BY ENDOSCOPIC REFERENCE SCORE IN CHILDREN WITH EOE: 52-WEEK RESULTS FROM THE PHASE 3 EOE KIDS TRIAL
Hirano, Ikuo
Schroeder, Shauna R.
Chehade, Mirna
Menard-Katcher, Calies D.
Hundal, Navneet Virk
Liu, Ruiqi
Abdulai, Raolat M.
Maloney, Jennifer
Glotfelty, Lila
Shabbir, Arsalan
GASTROENTEROLOGY, 2024, 166 (05) : S401 - S402
[4] DUPILUMAB IMPROVES HISTOPATHOLOGIC ENDPOINTS IN CHILDREN WITH EOSINOPHILIC ESOPHAGITIS: 52-WEEK RESULTS FROM THE PHASE 3 EOE KIDS TRIAL
Collins, Margaret H.
Rothenberg, Marc E.
Lerner, Diana G.
Pesek, Robert
Hundal, Navneet Virk
Liu, Ruiqi
Maloney, Jennifer
Abdulai, Raolat M.
Glotfelty, Lila
Shabbir, Arsalan
GASTROENTEROLOGY, 2024, 166 (05) : S402 - S402
[5] DUPILUMAB IMPROVES HISTOLOGIC AND ENDOSCOPIC ASPECTS OF EOSINOPHILIC ESOPHAGITIS IN CHILDREN AGED 1-11 YEARS IN THE PHASE 3 EOE KIDS TRIAL
Chehade, Mirna
Dellon, Evan S.
Spergel, Jonathan
Rothenberg, Marc E.
Liu, Ruiqi
Mannent, Leda
Laws, Elizabeth
Mortensen, Eric
Maloney, Jennifer
Khokhar, Faisel
Beazley, Bethany
Glotfelty, Lila
Shabbir, Arsalan
GASTROENTEROLOGY, 2023, 164 (06) : S112 - S112
[6] Dupilumab Improves Multiple Histopathologic Endpoints in Children With Eosinophilic Esophagitis: 52-Week Results From the Phase 3 EoE KIDS Trial
Collins, Margaret H.
Rothenberg, Marc E.
Lerner, Diana
Pesek, Robert D.
Hundal, Navneet Virk
Liu, Ruiqi
Maloney, Jennifer
Abdulai, Raolat M.
Louisias, Margee
Radin, Allen
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S456 - S457
[7] DUPILUMAB IMPROVES DISEASE SEVERITY AND QUALITY OF LIFE IN CHILDREN WITH EOSINOPHILIC ESOPHAGITIS: 52-WEEK RESULTS FROM THE PHASE 3 EOE KIDS TRIAL
Dellon, Evan S.
Oliva, Salvatore
Ashok, Dhandapani
Liu, Ruiqi
Glotfelty, Lila
Shabbir, Arsalan
Tilton, Sarette T.
Ge, Wenzhen
GASTROENTEROLOGY, 2024, 166 (05) : S401 - S401
[8] DUPILUMAB IMPROVES INFLAMMATORY AND REMODELING ASPECTS OF ENDOSCOPIC DISEASE ACTIVITY IN EOSINOPHILIC ESOPHAGITIS: 52-WEEK RESULTS FROM THE PHASE 3 LIBERTY EOE TREET STUDY
Hirano, Ikuo
Dellon, Evan S.
Pellegatta, Gaia
Xia, Changming
Pela, Tiffany
Durrani, Sandy
Jacob-Nara, Juby A.
Radwan, Amr
GASTROENTEROLOGY, 2024, 166 (05) : S402 - S403
[9] DUPILUMAB IMPROVES CLINICAL, SYMPTOMATIC, HISTOLOGIC, ENDOSCOPIC ASPECTS OF EOE: POOLED RESULTS FROM PHASE 3 LIBERTY-EOE-TREET
Dellon, E.
Rothenberg, M.
Hirano, I.
Bredenoord, A.
Lucendo, A.
Sun, X.
Patel, K.
Beazley, B.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S25 - S25
[10] DUPILUMAB IMPROVES INFLAMMATORY AND REMODELING ASPECTS OF ENDOSCOPIC DISEASE ACTIVITY IN EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE PHASE 3 LIBERTY-EOE-TREET STUDY
Hirano, Ikuo
Collins, Margaret H.
Dellon, Evan S.
Sun, Xian
Beazley, Bethany
Glotfelty, Lila
Shabbir, Arsalan
Giannelou, Angeliki
GASTROENTEROLOGY, 2023, 164 (06) : S346 - S346

← 1 2 3 →